Teva Pharmaceutical Industries Ltd. (TEVA)
29.80
+1.24
(+4.32%)
USD |
NYSE |
Dec 10, 16:00
29.87
+0.08
(+0.25%)
After-Hours: 20:00
Teva Pharmaceutical Industries Market Cap: 34.18B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 169.78B |
| Novo Nordisk A/S | 218.04B |
| Can-Fite BioPharma Ltd. | 4.815M |
| BiomX, Inc. | 4.137M |
| Nasus Pharma Ltd. | 58.62M |
Market Cap Related Metrics
| PE Ratio | 48.59 |
| PS Ratio | 2.037 |
| Price to Book Value | 4.715 |
| Price to Free Cash Flow | 136.91 |
| Price | 29.80 |
| Earnings Yield | 2.06% |
| Operating PE Ratio | 9.555 |
| Normalized PE Ratio | 17.94 |